Frequently asked questions

Yes, with a medical prescription. Anvisa (Brazil's health agency) regulates both pharmacy products and the import of cannabis-based products with a prescription. During the consultation you receive complete guidance on the right path for your case.

Yes. A digital prescription with a valid electronic signature is accepted throughout Brazil, both at pharmacies and in Anvisa procedures.

The consultation costs R$ 250 and is confirmed after payment via Pix. Follow-up pricing and the rescheduling policy are shared at booking.

Consultations are private. Many Brazilian health plans reimburse private consultations — we provide a receipt with everything you need to request yours.

Yes. Telemedicine is regulated by Brazil's Federal Council of Medicine (Resolution CFM 2.314/2022). The video call is private and your clinical data is protected in a secure electronic health record, in line with Brazil's data protection law (LGPD).

Treatments are individualized and, in most cases, use CBD-predominant formulations with low, carefully titrated THC doses when needed — planned for therapeutic effect, not recreation. Risks, side effects and contraindications are discussed openly during the consultation.

That assessment is a central part of the consultation: drug interactions are checked before any prescription, and no ongoing treatment should be stopped without guidance.

That happens — and we say so transparently. The consultation is a complete medical assessment: if cannabinoids are not the best path, you leave with guidance on the alternatives suited to your case.

Yes. Consultations are open to Brazilians living abroad, in Portuguese, English and Spanish. Feasibility and scope vary by country — contact us on WhatsApp so we can check your case. Appointment times are always shown in your timezone.